How many investments has Beyond Next Ventures made?

Beyond Next Ventures has 98 tracked investments, 1 of which have exited, including 5 dated in the last 24 months.

What stage does Beyond Next Ventures invest at?

Beyond Next Ventures invests at the Seed, Series A stages.

Where is Beyond Next Ventures located?

Beyond Next Ventures is headquartered in Tokyo, JP.

Does Beyond Next Ventures lead rounds?

Beyond Next Ventures typically participates in rounds rather than leading them.

Who does Beyond Next Ventures co-invest with?

Beyond Next Ventures most often shares deals with Kyoto University Innovation Capital, Global Brain, Shizuoka Capital, among 97 tracked co-investors.

Beyond Next Ventures

Venture capital

Tokyo · Seed–Series A · 36 people tracked

Also known as Beyond Next Ventures株式会社

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Beyond Next Ventures

1,666 people in our graph share verified history with the Beyond Next Ventures team — schools, employers, funds. One of them is your warm intro.

Kike Mirallesunlockedknows Masatoshi Honda · together at McKinsey & Company (overlapped)

knows the team · via University of Tsukuba

×6knows the team · via McKinsey & Company

knows the team · via RV College Of Engineering

knows the team · via Waseda University

×2knows the team · via University of Oregon

✨ Fox Verdict

Investment thesis

Beyond Next Ventures backs 'exceptional challengers' in deep tech, providing funding typically starting at the seed stage to top entrepreneurs and researchers across all deep-tech domains. Beyond capital, the firm runs incubation programs offering executive candidate matching, team building, business plan development, grant-funding support, and access to incubation wet lab facilities for spin-outs, carve-outs, academic labs, and solo founders. Since 2019 it has also invested in Indian deep-tech startups spanning healthcare, climate, agri-food, and AI, applying over a decade of Japanese deep-tech investing and ecosystem-building experience to support founders from lab to market.

Invests inAgTech AI & Machine Learning Biotech Climate Tech Deep Tech Digital Health FoodTech Healthtech Medical Devices Global India Japan Tokyo

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Tokyo, JP

Leads rounds

Follows

Instruments

Equity

Founded

2014

Last 12 months

1 investment

AUM

$340M

Tracked investments

IPOs

Team · 36 people

from the firm's website & curated & public directories

Jay Krishnan· Partner & Head of India Investment Groups (India)· Indiain

Jay Krishnan is an entrepreneur and investor with a background in hardware platforms, networking, and IoT, spanning engineering, product management, and strategy across India, the US, and Canada. He was CEO of Canada's Accelerator Centre and founding CEO of India's T-Hub, and worked as a venture partner at SRI Capital and Mantra Capital, covering investments from pre-seed to Series A. His earlier career included roles at Brooktrout-Cantata, Juniper Networks, and Cisco Systems, and he exited DDI and Radifinity Inc. through IP and asset sales. He is also a published author.

Kengo Ueha· Partner· Tokyoin

Kengo Ueha has more than 20 years of experience in venture capital. He joined Beyond Next Ventures as a Co-Founding Partner in 2015 and became Managing Director in 2023, where he oversees fund management, corporate operations, and the firm's investment activities. He previously worked at JAFCO starting in 2003, handling investment execution and finance/administrative operations, and holds a Bachelor of Laws from Chuo University.

u•••@beyondnextventures.comreveal

Tsuyoshi Ito· Managing Partner· Tokyoin 𝕏

Tsuyoshi Ito founded Beyond Next Ventures in 2014 with the goal of returning financial gains to academia and supporting the deep-tech startup ecosystem. He previously joined JAFCO in 2003, where he led investments in university spin-offs, and currently serves as an outside director for portfolio companies and as a Visiting Professor at Nagoya and Hiroshima Universities. He holds a Master's in Chemical Engineering from Tokyo Institute of Technology.

i•••@beyondnextventures.comreveal

Yuichiro Sano· Partner· Japanin 𝕏

Yuichiro Sano joined Beyond Next Ventures in 2021 and leads the firm's India Investment Team, focusing on investments in Indian startups and the firm's global impact investing strategy. He previously spent over 15 years working in emerging markets at JBIC and JICA, including three years in India managing financial projects across debt and equity and starting startup investment programs. He holds a Bachelor's degree from Waseda University and a Master in Public Policy from Harvard Kennedy School.

Hiroyuki Kageyama· Principal / Investment Gr.· Tokyo, Japanin

Hiroyuki Kageyama joined Beyond Next Ventures in August 2023 as a venture capitalist focused on bridging science and its application in society. Before that, he worked at Accenture from 2020 as a strategy consultant on new business development projects for clients in the telecommunications and financial industries. He holds a graduate degree from the Graduate School of Science at The University of Tokyo, where his research covered ultrafast vibrational dynamics of molecules under intense laser fields using femtosecond laser equipment.

Keigo Yato· Principal, Investment Group (Ph.D.)𝕏

Keigo Yato holds a Ph.D. and previously conducted research on hepatitis vaccines and viral immune response at the National Institute of Infectious Diseases. He joined Beyond Next Ventures as a student intern during his doctoral studies and became a full-time employee in April 2022, where he focuses on investments in biotechnology and drug discovery.

Masahiro Goto· Principal / Investment Gr.· Greater Tokyo Areain

Masahiro Goto joined Beyond Next Ventures in April 2024, where he focuses on investing in the climate tech sector, with an interest in clean and domestic energy in Japan. He began his career at Toyota Tsusho Corporation in April 2013 trading automotive chemical materials, later working on materials engineering at Toyota Motor Corporation and hydrogen projects in Shanghai, before joining Mitsubishi UFJ Capital in January 2022 to invest in startups with a focus on deep tech. He holds a master's degree in engineering from the Graduate School of Pure and Applied Sciences at the University of Tsukuba.

Masatoshi Honda· Advisor, Venture Partner· New York, New York, United Statesin

Akiko Fujii· Investment Gr.

Akiko Fujii studied supply chain management and customer satisfaction at university and holds a Master's degree in Industrial Engineering and Management from Tokyo Institute of Technology. In April 2021 she joined SMBC Nikko Securities' Investment Banking Division, supporting M&A and fundraising execution primarily for financial institutions. She joined Beyond Next Ventures as a venture capitalist in December 2024.

Akira Horiguchi· Adviser

Former Executive Vice President of Kobayashi Pharmaceutical with over 40 years in medical device manufacturing and sales in Japan and the US.

Akito Arima· Investor· Tokyoin 𝕏

Akito Arima joined Beyond Next Ventures in 2019, where he invests in Agri-FoodTech, bio-manufacturing, and climate tech. He was named Partner in 2022 and Head of the Open Innovation Department in 2025, and founded the TECHNIUM Global Conference. He serves as Project Manager for the MAFF SBIR program and Representative Director of Next Prime Food, previously worked in the Grain Division at Marubeni Corporation, and holds a degree in Biosciences and Informatics from Keio University.

a•••@beyondnextventures.comreveal

Devang Thakor· Adviser

Founder/President of Anioplex, LLC; a biopharma executive, scientist, and patent/corporate attorney, formerly a USPTO pharmaceutical patent examiner and researcher at Harvard, Kyoto University, and UCLA.

Hiroki Matsumoto· Adviser

Representative of SubTonic Consulting with an MBA from the University of Chicago and cross-industry experience spanning medtech, steel, wine, and software.

Karthik Varada· Senior Associate / Investment Gr. (India)· Indiain 𝕏

Karthik Varada works on new investments in Indian startups and supports the growth and impact visibility of portfolio companies at Beyond Next Ventures. He previously was a postdoctoral researcher at the University of Tokyo studying ESG and climate-tech investments, and was a founding member of the Sasakawa Peace Foundation's Asia Women Impact Fund, an impact fund focused on gender equality. He holds a PhD and a master's degree from the University of Tokyo, and an undergraduate engineering degree from IIT Hyderabad.

Katsuya Hashizume· Investor· Tokyoin 𝕏

Katsuya Hashizume is a Partner and Head of the Investment Department at Beyond Next Ventures, where he has led investment strategy since 2022. He joined the firm in 2020 and brings more than 15 years of experience nurturing academic ventures, supporting startups from pre-seed through commercialization and growth. His earlier career includes a Group Leader role at JAFCO and work as a representative promoter for JST START, and he holds a Master's degree from Keio University.

h•••@beyondnextventures.comreveal

Keisuke Nakamura· Adviser

CEO of FOODBOX Co., Ltd., providing consulting in food and agriculture to companies, local governments, and farmers.

Kohei Takeshita· Adviser

Assistant Professor at Tokyo Jikei University and former PMDA medical device reviewer, researching medical IT and devices and advising ventures.

Koji Nakao· Adviser

Founder of the Japan Biodesign Association, former Chairman of Terumo Corporation, and CEO of Art Management Shimanami LLC.

Mana Yada· Senior Associate / HR Strategy Gr.· Barcelona, Catalonia, Spainin

Mana Yada graduated from ICU and began her career at a recruitment agency, working on career transition support for professional services roles and corporate executive positions. Over her career she supported roughly 50 client companies and more than 900 candidates, served as a guest lecturer at a university, handled internal recruiting, and worked as a Director leading her own team. She later earned an MBA from ESADE Business School before joining Beyond Next Ventures, where she works in the HR Strategy Group.

Masatoshi Honda· Adviser· New York

Associate Professor at Kyoto University's Society-Academia Collaboration for Innovation, former McKinsey consultant, co-founder of GRA&GREEN, and a Forbes Asia 30 Under 30 honoree.

Masaya Eshita· Executive Officer / Fund & Corporate Manager

Masaya Eshita is an Executive Officer and Head of the Fund & Corporate Division at Beyond Next Ventures, where he oversees fund administration, finance and accounting, HR, general affairs, and public relations, and manages the firm's Beyond BioLAB TOKYO shared wet-lab facility. He joined the firm in 2020 and was appointed Executive Officer in 2026. He previously worked at LEVEL-5 Inc. starting in 2011 and at Recruit Career (now Indeed Recruit Partners) from 2018, and holds a B.A. in Economics and Business Administration from Kyushu University.

Masayuki Kawahara· Adviser

A physician with over 10 years in medical devices and drug development, including four and a half years as a reviewer at Japan's PMDA, now working in clinical development consulting.

Mitsuhiro Kimura· Adviser

Auditor at MIRAI NIHON VENTURES and former Deputy Head of Corporate Clients at SMBC Nikko Securities with 26 years of IPO and startup support experience.

Miyu Yamamoto· Investment Groupin 𝕏

Miyu Yamamoto joined Beyond Next Ventures in November 2023, working on open innovation and acceleration with a focus on supporting academic research funding in Japan. She previously worked at Nomura Research Institute on industry-academia-government collaboration, startup support, and new venture development in the medical and energy sectors, and held a part-time role at the R&D startup BIOTA doing research, grant management, and recruiting. She completed graduate studies in the Department of Earth and Planetary Environmental Science at the University of Tokyo.

Miyuki Shimizu· Adviser

CEO of Medical Lab Partners Corporation with 17 years of medical device development experience at Terumo, now consulting on medical device development.

Risa Aki· Senior Associate / Investment Gr.

Seiichi Saito· Head of Business Development

Seiichi Saito began his career at Maruha Nichiro and later worked at the Australian Embassy in Japan before joining the JAFCO Group in 1998. From 2008 he worked on Fund of Funds formation and investment operations at AI Capital, and in 2014 became a Director at Rothschild & Co, managing European private equity funds with investors across Japan and Asia. He joined Beyond Next Ventures in April 2023, where his role focuses on investor relations. He holds an Economics degree from Sophia University, Tokyo, and an MBA from Warwick Business School in the UK.

Shinichi Koizumi· Adviser

A Medicinal Creation Advisor and Representative Director; co-founder of RaQualia Pharma and AskAt, and a professor at Chiba University Graduate School of Medicine.

Shota Sagiyama· Executive Officer / Talent Partner / HR Strategy Manager· Tokyo, Tokyo, Japanin 𝕏

Shota Sagiyama joined Beyond Next Ventures in 2017, where he focuses on executive search and team building for deep-tech startups, helping recruit co-founders and CXOs. He leads the firm's INNOVATION LEADERS PROGRAM, which has produced over 50 startup executives and supported 300+ strategic hires for portfolio companies. He is a certified Career Development Advisor and Career Consultant, and previously built a management talent practice for university ventures at Tokio Marine Nichido Career Service starting in 2007, after joining Quick Co., Ltd. in 2002.

Taiji Edogawa· Adviser

Representative Partner at EDiX Professional Group / Edogawa Certified Public Accountant Office. A certified public accountant who has helped many startups, including life science and IT companies, go public and advises on innovation policy.

Takehiko Sawabe· Director / Investment Gr.· Greater Tokyo Areain

Takehiko Sawabe leads Beyond Next Ventures' investments in biotech start-ups. He previously served as Managing Director at INCJ, backing biotech companies including Stella Pharma, Megakaryon, and Scohia Pharma, and earlier held roles at Meiji Seika (as a medicinal chemist and later in business development), Johnson & Johnson (medical device business development), and AbbVie (Japan portfolio management). He holds a Master's degree from the University of Tokyo's Graduate School of Pharmaceutical Sciences and an MBA from GLOBIS University.

Yasuhisa Matsukawa· Adviser

Affiliated with the Kawasaki Institute of Industrial Promotion, with drug discovery and regenerative medicine experience at Mitsubishi Tanabe and Takeda Pharmaceutical.

Yasutaka Kashiwagi· M.D. / Senior Associate / Investment Gr.in

Yasutaka Kashiwagi trained clinically at Jikei University Kashiwa Hospital before working at the global consulting firm ZS Associates, where he supported new business development strategy, pricing, and product evaluation for pharmaceutical and medical device companies. He joined Beyond Next Ventures in 2025 to focus on investments in medical devices and digital health. He holds an M.D. from Jikei University School of Medicine.

Yoshihito Daimon· Adviser

A patent attorney and IP strategist with a background at Astellas Pharma, undefeated in IP litigation, and a specially appointed professor at Tohoku University.

Ashish Behera· Investor· London

Mayu Yoshikawa· Investor· Japanin

Founder mafia

2 people who came through Beyond Next Ventures went on to found or lead other companies.

Katsuya HashizumeInvestorFounded Futuredme Shinya KinaEIRFounded Minacolor

What they invest in

from 46 of 98 portfolio companies

Healthtech ×22Medical Devices ×21Deep Tech ×15AI & Machine Learning ×13Digital Health ×13Hardware ×11Biotech ×10SaaS ×7

HQs:Japan×32India×8United States×4Singapore×1

Who they back

founder profiles across 25 portfolio companies

44%

solo founders

11 of 25 mapped founding teams

62%

repeat founders

of 21 founders with career history

Founding team size:solo founder×112 founders×113 founders×24+ founders×1

Where their founders studiedfrom 17 founders with education data

Bishop Cotton Boys' School ×2Indian Institute of Technology, Delhi ×2Indian Institute of Technology, Madras ×2The Hong Kong University of Science and Technology ×2Tohoku University ×2

What their founders studiedfrom 17 founders with field-of-study data

Engineering ×7Business & Management ×3Finance & Accounting ×2Medicine ×2

Where their founders worked beforefrom 21 founders with career history

Massachusetts Institute of Technology ×2

Investments · showing 94 of 98

founders shown can be your intro path

By year:2026 · 1 2025 · 1 2024 · 1 2022 · 1 2020 · 37 dated

Cytoronixcytoronix.com 𝕏✓ verified

Cytoronix develops cell-observation technology using CMOS image sensors, a technology originally started at Toshiba's R&D Center.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSemiconductorsYokohama, JP

Neautechneautech.jp✓ verified

Neautech operates an online medical beauty treatment platform (ANS.) that connects patients with doctors for skin concerns, develops functional cosmetics based on diagnostic data, and builds healthcare technology infrastructure including AI systems co-developed with Panasonic.

ConsumerDigital HealthHealthtechMedical DevicesTokyo, JP

Akihiro Mizumoto(CEO)Shirika Murayama(Director / ANS. Business Division Head / Physician)Yuko Kanazawa(Director / Medical Platform Business Division Head)

Co-investorsDEEPCORE Inc.

Visban Developing AI-driven millimeter-wave netvisban.com✓ verified

Visban develops continuous millimeter-wave (mmWave) coverage technology to enable real-world deployment of wireless networks.

AI & Machine LearningDeep TechHardwareTokyo, JP

S.B. Cha(CEO/Co-Founder)Ryosuke Kuwada(Chief Business Officer/Co-Founder)Arokia Nathan(Chief Science Officer/Co-Founder/Director)in

Co-investorsUTokyo Innovation Platform Co. Ltd.

Aillisaillis.jp

Sho Okiyama(Founder)in

Co-investorsFunds Startups i-nest capital STRIVE Z Venture Capital Aozora Corporate Investment

Alchemedicinealchemedicine.com

Alchemedicine is a drug discovery company focused on research and development of new small-molecule medicines, using its proprietary synthesis technology HiSAP® to improve on existing drugs' weak efficacy, side effects, and pharmacokinetics.

BiotechDeep Tech

Anaut Surganaut-surg.com

Anaut develops medical devices for surgical support using artificial intelligence and advanced technology to enhance surgeon capabilities and patient safety during surgical procedures.

AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP

Nao Kobayashi(Representative Director (代表取締役))Kensuke Hosomi(Director (取締役))

Co-investorsVision Incubate

Biomonetabiomoneta.com in 𝕏Jun 2020

Biomoneta develops air decontamination devices that use ZeBox technology to eliminate airborne pathogens and provide medical-grade sterility without ozone or harmful radiation.

BiotechHardwareHealthtechMedical DevicesBangalore, IN

Janani Venkatraman(Co-founder & Director)inSantanu(Co-founder & Director)Arindam(Co-founder & Chief Executive Officer)

Co-investorsMalpani Ventures

Boston Medical Sciencesb-ms.tech

The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsGlobal Brain JIC Venture Growth Investments

CureAppcureapp.co.jp 𝕏Oct 2024

CureApp HT is a smartphone application that helps patients manage hypertension through self-monitoring of blood pressure and lifestyle changes, with supporting guidance from physicians.

AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP

Kohta Satake, MD, MPH, MBA(Founder)in

Co-investorsKeio Innovation Initiative

DocsAppmedibuddy.in in 𝕏

India's leading digital healthcare platform, which closed a $40M Series B round.

Satish Kannan(Founder)inEnbasekar D(Founder)in

Co-investorsBessemer Venture Partners FinSight Ventures Powerhouse Ventures Rebright Partners InnoVen Capital

EF Polymerefpolymer.com in

EF Polymer makes a 100% natural super-absorbent polymer produced by upcycling agricultural waste such as fruit peels and pulp.

AgTechCircular EconomyNew Materials

Narayan Lal Gurjar(Founder)in Ankit Jain(Founder)in

Co-investorsLifetime Ventures SVG Ventures | THRIVE Universal Materials Incubator

Equmenopolisequ.ai

Tokyo, JP

Keita Miyamura(Founder)

Co-investorsShizuoka Capital

Exmedexmed.io 𝕏

ExMedio provides an IT platform called Hipokura that enables physicians across specialties to share clinical knowledge, seek specialist consultations, and discuss cases to improve diagnostic and treatment quality.

Digital HealthHealthtechMedical DevicesSaaSTokyo, JP

Keiji Sawada

Faunatechsolutionsfaunatechsolutions.com in

FaunaTech develops handheld diagnostics tools for testing food quality and animal health biomarkers at point-of-use in agricultural settings.

AgTechFoodTechHardwareHealthtechBangalore, IN

FELIQSfeliqs.com

FELIQS is a clinical-stage ophthalmology company developing therapies for neonatal and age-related eye diseases, including Retinopathy of Prematurity, Pterygium, and Geographic Atrophy/wet AMD.

BiotechHealthtechMedical Devices

Final Layerfinallayer.com in 𝕏

FinalLayer is an AI-powered LinkedIn post generator that helps creators, founders, and professionals create personalized viral content in minutes.

AI & Machine LearningCreator EconomyMarketing TechSaaS

Vidya(Co-founder)Lakshminath(Co-founder)

Co-investorsFjor Founders

fulldepthfulldepth.co.jp 𝕏

FullDepth develops and manufactures industrial underwater drones (autonomous vehicles) for inspection and survey operations in marine and subsea environments.

Deep TechHardwareRoboticsTokyo, JP

Shohei Ito(Director (formerly Representative Director & CEO))Satoshi Yoshiga(Representative Director & CEO)

Co-investorsDRONE FUND ZENRIN FUTURE PARTNERS

Gojo Companygojo.co in

Gojo & Company is a Japan-based financial inclusion group that invests in and operates microfinance institutions, banks, and fintech companies across Asia and Africa to expand access to financial services for underserved clients.

Enterprise SoftwareFintechImpact & Social GoodSaaSTokyo, JP

Taejun Shin(Co-founder, Managing Partner & CEO)Sanjay Gandhi(Co-founder & CIO)inArnaud Ventura(Managing Partner)Kohei Katada(Managing Partner / CFO)Gurol Michael Sari(Chief Operating Officer)Takao Takahashi(Chief People & Inclusion Officer)in

Co-investors15th Rock DIMENSION Fujitsu Ventures Globis Capital Partners GMO VenturePartners KDDI Open Innovation Fund +3 more

GRA&GREENgragreen.com in

GraGreen develops improved crop varieties using genome editing and traditional breeding methods to reduce resource inputs and increase agricultural yields.

AgTechClimate TechNagoya, JP

Masaki Niwain

Co-investorsKyoto University Innovation Capital Seiho Investment Works Shizuoka Capital Techstars UTokyo Innovation Platform Co. Ltd.

GroMogromo.in in 𝕏Jun 2022

GroMo is a platform that enables individuals to earn income by selling financial products from partner brands within their networks.

B2B MarketplacesFintechInsurTechMarketing TechSaaSGurugram, IN

Ankit Khandelwal(Founder)in Darpan Khurana(Founder)in

Co-investorsFirst Cheque Kube VC Tracxn labs Y Combinator ACE & Company Goodwater Capital +1 more

HITOTSU株式会社hitotsu.co.jp

HITOTSU develops digital transformation software for hospitals and healthcare providers, including communication tools, messaging platforms, and incident reporting systems.

Digital HealthEnterprise SoftwareSaaSTokyo, JP

佐藤公彦(代表取締役)

Co-investorsAngel Bridge Co.,Ltd.

iCAREicare.jpn.com

.JPN.COM is a domain registry offering .jpn.com domains as an alternative to traditional Japanese ccTLDs, providing unrestricted global access to Japan-focused digital presence without residency or business registration requirements.

Sector AgnosticLas Vegas, US

Co-investorsGlobal Brain Sumitomo Mitsui Finance and Leasing Incubate Fund

ImpactGuruimpactguru.com in

Technology-enabled integrated healthcare financing platform spanning crowdfunding, healthcare lending, and health insurance distribution.

Khushboo Jain(Founder)in Piyush Jain(Founder)in

Co-investorsHealthQuad Shorooq Partners

IntegriCultureintegriculture.com in 𝕏May 2020 · $7.4M

IntegriCulture is a Japanese cellular agriculture company developing cell-culture systems and production technology for cultured foods, along with OEM/ODM cosmetics and supplements and sales of cell-culture consumables and equipment.

BiotechDeep TechFoodTechFujisawa, JP

Yuki Hanyu(代表取締役 (CEO))in

Co-investorsHiroshima Venture Capital Co. Ltd.Iyogin Capital Spiral Capital AgFunder VU Venture Partners

IntegriCultureintegriculture.jp

Yuki Hanyu(Founder)in

Co-investorsUntroD Capital VU Venture Partners AgFunder

KANJIN THERAPEUTICS, INC.kanjin-tx.com

Kanjin Therapeutics is a biotechnology startup developing treatments to restore kidney function and address chronic kidney diseases, using a strategy of targeting the liver.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsKyoto University Innovation Capital

Lil' Goodnesslilgoodness.comMay 2020

Lil Goodness makes chocolate using single-origin, organic cacao beans sourced from Ghana and Ecuador, produced through a "bean to bar at source" process in India.

ConsumerDirect to ConsumerFoodTech

MabGenesismabgenesis.com

MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use.

BiotechDeep TechHealthtech

Co-investorsLong Black Partners

MEDFIN** Elective Surgeriesmedfin.in in 𝕏

Medfin helps patients in India access surgical care by connecting them with a network of doctors and hospitals, managing health insurance processing, and offering no-cost EMI financing for procedures.

Digital HealthFintechHealthtech

Arjun Kumar(Founder)in

Co-investorsAxilor Ventures Sony Ventures Corporation

Metcelametcela.com

Metcela is a Japanese biotech company developing science-backed therapies for pediatric and rare diseases, with in-house capabilities spanning research through development.

BiotechHealthtechMedical Devices

Co-investorsF-Prime Capital OSAKA University Venture Capital Sony Ventures Corporation UTEC

Museincmuseinc.in in

Muse develops eTAAL, a USB-C digital stethoscope, and eMurmur auscultation software that lets users record, filter, store in the cloud, and live-stream heart and lung sounds for telemedicine and remote patient monitoring.

Digital HealthHardwareMedical Devices

Myelinmyelin.vcAug 2026 · $1M

Myelin is an industry-agnostic venture capital firm that invests in founders from seed through Series A.

Sector Agnostic

Co-investorsJazzya Investments VNV Global Endiya Partners SIDBI Venture Capital

Myelin Foundrymyelinfoundry.com 𝕏

Myelin Foundry develops edge AI solutions for automotive, industrial, and media applications, including in-car assistants, smart factory inspection systems, and video enhancement tools.

AI & Machine LearningDeep TechBangalore, IN

Co-investorsEndiya Partners

Myoridgemyoridge.co.jp in

Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications.

BiotechHealthtechMedical DevicesJapan, JP

Co-investorsDiamond Edge Ventures Kyoto University Innovation Capital

Nbmed Incnbmed-inc.com

N.B.

AI & Machine LearningHealthtechMedical DevicesTokyo, JP

Kazuya Shobayashi(President & CEO)

OPExPARKopexpark.co.jp

OPExPARK uses IoT technology to digitize operating rooms and standardize surgical practices globally.

Digital HealthHealthtechIoTMedical DevicesTokyo, JP

本田泰教(代表取締役 (Representative Director))

Orylaborylab.com 𝕏

A technology company that develops avatar robots and communication tools to enable people with physical disabilities and mobility constraints to participate in society and work remotely.

AI & Machine LearningFuture of WorkHardwareHealthtechHR TechMedical DevicesRoboticsTokyo, JP

Kentaro Yoshifuji(Co-founder, Representative Director, CVO)Yoshifumi Shiiba(Co-founder, Director CTO)

Co-investorsUntroD Capital

QD Laserqdlaser.com

QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices.

Deep TechHardwareMedical DevicesSemiconductorsYokohama, JP

Mitsuru Sugawara(Founder)in菅原充(Founder & Chief Technology Advisor)大久保潔(President & Representative Director)

Co-investorsMIRAI SOUZOU Mitsui Global Investment Oita Venture Capital SMBC Venture Capital UntroD Capital UTokyo Innovation Platform Co. Ltd.+1 more

Redarrowtxredarrowtx.com

Red Arrow Therapeutics develops cancer therapies using a proprietary nanopolymer drug-delivery system for programmable encapsulation and release of biologics such as peptides, antibodies, and proteins.

BiotechHealthtechMedical DevicesCambridge, US

Horacio Cabral(Scientific Founder / Technology Pioneer)Philipp Steiner(Chief Scientific Officer (CSO))

Co-investorsOSAKA University Venture Capital UTEC

SUSMED 2021susmed.co.jp

SUSMED (サスメド株式会社) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning.

AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP

上野太郎(代表取締役社長)Taro Ueno, M.D., Ph.D(Founder)in本橋智光(取締役 CTO)

Partner Kengo Ueha· led

Co-investorsDIMENSION Sony Ventures Corporation

Symbiobe株式会社symbiobe.jp

Koji Itoin

Co-investorsEnergy & Environment Investment Global Brain Kyoto University Innovation Capital

Trudocgrouptrudocgroup.com in 𝕏

TruDoc provides chronic disease management and telehealth services, offering round-the-clock access to medical care, symptom checking, emotional health support, and personalized health metrics.

Digital HealthHealthtech

Abhishek Shah(President)inAsad Khan(CEO)inVish Narain(Executive Chairman)inUtsaav Pathak(Group Finance Director)in

UMAMI UNITED株式会社umamiunited.com

Umami United develops shelf-stable, plant-based egg replacement ingredients for food manufacturers, including a binder product for industrial baking that provides binding, water retention, and shape retention.

FoodTechTokyo, JP

Hiroto Yamazaki(Founder)in

Co-investorsmint VC Big Idea Ventures Genesia Ventures

Universal Brainuniversal-brain.com in

Universal Brain develops a neuroscience-based platform that uses an EEG wearable and a digital ERP (event-related potential) interface to measure brain function and group patients into "neurotypes" for psychiatric conditions, starting with depression.

Digital HealthMedical DevicesMental Health

Kazu Okuda, MD(Founder)in

Volt14 Solutionsvolt14.com inMay 2025

Volt14 Solutions develops silicon-majority anode materials that replace conventional graphite anodes in lithium-ion battery cells, aiming to increase energy density and lower cost while remaining compatible with existing cell manufacturing infrastructure.

Advanced ManufacturingCleantechDeep TechEnergyNew MaterialsSaaSSingapore, SG

Animesh Jhar(Cofounder)inAdam Haldar(Cofounder)inAnimesh JhainArindam Haldar

Co-investors500 Global Cocoon Capital Entrepreneur First Supermorpheus Blume Ventures

エレファンテックelephantech.co.jp

Shimizu Shinya(Founder)inSugimoto Masaaki(Founder)in

Co-investorsGlobal Brain Shizuoka Capital

さかなドリームsakana-dream.com

A Japanese company that selects underutilized fish species from Japan's over 4,000 varieties and uses advanced aquaculture technology to produce high-quality farmed fish for global markets.

AgTechFoodTech

Shunichiro Hosoya(Founder)in

Co-investorsGlobal Brain Spiral Capital Spiral Innovation Partners

ライノフラックスrhinoflux.com

Atsushi Alex Mazawa(Founder)in

Co-investorsGlobal Brain Kyoto University Innovation Capital

リバーフィールド株式会社riverfieldinc.com in

Riverfield develops surgical robotic systems that provide force feedback and control similar to human hands, enabling safer and more precise robot-assisted surgery.

AI & Machine LearningDeep TechHealthtechMedical DevicesRoboticsTokyo, JP

只野耕太郎Kota Tadano只野耕太郎

Co-investorsHiroshima Venture Capital Co. Ltd.Japan Post Capital Co. Ltd.

株式会社Acompanyacompany.tech

Offers the 'Confidential AI Suite' security product brand centered on confidential computing to safely connect data and AI.

Ryosuke Takahashi(Founder)in

Co-investorsDG Daiwa Ventures Funds Startups Globis Capital Partners

株式会社ElevationSpaceelevation-space.com in 𝕏

ElevationSpace develops small-satellite re-entry and recovery technology to return the results of in-orbit experiments to Earth, aiming to build an orbital transport network for people and goods.

Deep TechHardwareSpace Tech

Ryohei Kobayashi(Founder)in

Co-investorsCanal Ventures Global Brain MIRAI SOUZOU NTT DOCOMO Ventures Seraphim Space Z Venture Capital +1 more

株式会社KOALA Techkoalatech.co.jp in

KOALA Tech Inc. is a Kyushu University spinout commercializing organic semiconductor laser diode (OSLD) technology as laser light sources compatible with organic electronic device platforms, including OLED displays.

Deep TechHardwareSemiconductorsFukuoka, JP

安達千波矢(Founder (Kyushu University Professor))Chihaya Adachi(Co-founder (Kyushu University Professor))Fatima Bencheikh(Representative Director, CEO & CTO)in

Co-investorsKyoto University Innovation Capital Sony Ventures Corporation

株式会社LabBase Active Human Resourceslabbase.co.jp

LabBase is a Japanese company that operates recruitment and career services, with content indicating a focus on science and technology (STEM) talent.

EdTechHR TechMarketplacesSaaSTokyo, JP

Michiaki Kamo(代表取締役CEO (Representative Director & CEO))in

Co-investorsJIC Venture Growth Investments PKSHA Technology Capital

株式会社LIFESCAPESlifescapes.jp

Lifescapes develops brain-machine interface (BMI) technologies, including medical-grade and rehabilitation-focused devices for hand and finger control applications.

AI & Machine LearningDeep TechHealthtechMedical DevicesTokyo, JP

Junichi Ushiba(Chairman (Founder, BMI Developer))Masaaki Hayashi(Representative Director, CEO)in

Co-investorsX-HUB TOKYO Global Startup Accelerator

株式会社Photo electron Soulphotoelectronsoul.com in

Photo Electron Soul develops and manufactures electron beam generation devices and components for research and industrial applications.

Advanced ManufacturingDeep TechHardwareSemiconductorsNagoya, JP

鈴木孝征(Representative Director (代表取締役))西谷智博(Director, Technology Development (取締役技術開発担当))田村逸郎(Director, Management Planning (取締役経営企画担当))土谷滋(Director, Business Operations (取締役事業統括担当))

Co-investorsi-nest capital Japan Post Capital Co. Ltd.Shizuoka Capital

株式会社Yaqumoyaqumo.com

Yaqumo develops neutral atom quantum computers designed to solve complex computational problems across materials, chemicals, pharmaceuticals, and finance sectors.

Deep TechHardwareQuantum ComputingTokyo, JP

Kazuhiro Nakakoji

Co-investorsJIC Venture Growth Investments Kyoto University Innovation Capital Quantonation

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

㈱スコヒアファーマAlgaleXALYAqua TheonATOMBigHaatBolt MedicalEF Polymer Private LimitedEmiumEthicalspiritsexMedioGeneric AadhaarGigIndiaI'mbesideyouK3RKOALA TechMUSE DiagnosticsN.B.MedicalPhasorz TechnologyPRECISIONPremediRed Arrow TherapeuticsRegional FishRepertoire Genesis株式会社RIVERFIELDSCOHIA PHARMASECAI MARCHESonoligoT.G.MedicalThe Ethical Spirits & Co.TOWINGTruDocVisbanПройти интервьюアナウト株式会社 (Anaut)ファーメランタ株式会社株式会社BiPSEE株式会社GramEye

Portfolio news

latest coverage across their companies

ImpactGuru Expands Access to Medical Crowdfunding in India, Helping Families Raise Funds for Critical Healthcare Needs

ImpactGuru · openpr.com · Aug 17, 2026

Deep tech AI Startup Myelin Foundry raises $1 million from Beyond Next Ventures & Others

Myelin · siliconindia.com · Aug 8, 2026

Earn Commission with GroMo: India Investment Opportunities 2026

GroMo · gromo.in · Jul 10, 2026

Biomoneta Secures $500K Seed | Signalbase

Biomoneta · trysignalbase.com · Mar 24, 2026

CureApp, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

CureApp · bitscale.ai · Mar 19, 2026

EF Polymer secures $17.8 million funding for sustainable innovation

EF Polymer · iamrenew.com · Oct 17, 2025

Announcement of Our Investment in Volt14 Solutions | Beyond Next Ventures

Volt14 Solutions · beyondnextventures.com · May 14, 2025

Boston Medical Sciences, developer of laxative-free virtual endoscopy system, raises additional $9.3 million

Boston Medical Sciences · itbusinesstoday.com · May 6, 2025

Frequently asked questions

How many investments has Beyond Next Ventures made?: Beyond Next Ventures has 98 tracked investments, 1 of which have exited, including 5 dated in the last 24 months.
What stage does Beyond Next Ventures invest at?: Beyond Next Ventures invests at the Seed, Series A stages.
What sectors does Beyond Next Ventures focus on?: Beyond Next Ventures focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Digital Health, FoodTech, Healthtech, Medical Devices.
Where is Beyond Next Ventures located?: Beyond Next Ventures is headquartered in Tokyo, JP.
Does Beyond Next Ventures lead rounds?: Beyond Next Ventures typically participates in rounds rather than leading them.
Who does Beyond Next Ventures co-invest with?: Beyond Next Ventures most often shares deals with Kyoto University Innovation Capital, Global Brain, Shizuoka Capital, among 97 tracked co-investors.

Images

Co-investors · 5

Z Venture Capital

Z Venture Capital is a venture capital firm that invests in and supports innovative startups pursuing transformative societal change, drawing on the resources, expertise, and assets of the LY Corporation Group.

Both backed · 2

株式会社ElevationSpaceAillis

$150K – $101M

AgFunder

AgFunder is a venture capital firm focused on the agrifoodtech sector, and also publishes research such as its annual Global AgriFoodTech Investment Report.

Both backed · 1

IntegriCulture

$10K – $5M

VU Venture Partners

VU Venture Partners is a global early-stage technology venture capital fund investing across the world's largest market opportunities, operating with a large investment team and six vertical-focused practices.

Both backed · 1

IntegriCulture

$200K – $1M

BEENEXT

BEENEXT is a global venture firm built around a community of founders and investors, having backed around 180 companies across 17 countries and 5 continents.

$500K – $50M

Season Two Ventures

An early-stage and growth-stage B2B venture capital firm investing across technology, fintech, and healthcare sectors with a founder-centric approach.

Firms observed investing alongside Beyond Next Ventures, from public investor directories. Shared companies are the overlap with Beyond Next Ventures's recorded portfolio.

Similar investors

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Overwater Ventures Llc

Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.

$400K – $2M

Voima Ventures

Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.

$216K – $3.2M

Seventure Partners

Seventure Partners is a European venture capital firm, founded in 1997 and a subsidiary of Natixis Investment Managers, investing in digital technologies and life sciences companies with strong growth potential.

BDC Fund Investments (Fund-of-Funds)

This page is the analysis and research library of the Business Development Bank of Canada (BDC), publishing studies, surveys and reports on issues affecting small and medium-sized businesses in Canada.

Featured in lists

Seed Investors & VC Firms Series A Investors & VC Firms Investors & VC Firms in Global AI & Machine Learning Investors & VC Firms Investors & VC Firms in Asia-Pacific Healthtech Investors & VC Firms AI & Machine Learning Seed Investors & VC Firms Seed Investors & VC Firms in Global Healthtech Seed Investors & VC Firms AI & Machine Learning Series A Investors & VC Firms Seed Investors & VC Firms in Asia-Pacific Deep Tech Investors & VC Firms